Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population - PubMed (original) (raw)
Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population
L S Friedman et al. Am J Hum Genet. 1997 Feb.
Abstract
A population-based series of 54 male breast cancer cases from Southern California were analyzed for germ-line mutations in the inherited breast/ovarian cancer genes, BRCA1 and BRCA2. Nine (17%) of the patients had a family history of breast and/or ovarian cancer in at least one first-degree relative. A further seven (13%) of the patients reported breast/ovarian cancer in at least one second-degree relative and in no first-degree relatives. No germ-line BRCA1 mutations were found. Two male breast cancer patients (4% of the total) were found to carry novel truncating mutations in the BRCA2 gene. Only one of the two male breast cancer patients carrying a BRCA2 mutation had a family history of cancer, with one case of ovarian cancer in a first-degree relative. The remaining eight cases (89%) of male breast cancer with a family history of breast/ovarian cancer in first-degree relatives remain unaccounted for by mutations in either the BRCA1 gene or the BRCA2 gene.
Similar articles
- Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families.
Ikeda N, Miyoshi Y, Yoneda K, Shiba E, Sekihara Y, Kinoshita M, Noguchi S. Ikeda N, et al. Int J Cancer. 2001 Jan 1;91(1):83-8. doi: 10.1002/1097-0215(20010101)91:1<83::aid-ijc1013>3.0.co;2-5. Int J Cancer. 2001. PMID: 11149425 - High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history.
Csokay B, Udvarhelyi N, Sulyok Z, Besznyak I, Ramus S, Ponder B, Olah E. Csokay B, et al. Cancer Res. 1999 Mar 1;59(5):995-8. Cancer Res. 1999. PMID: 10070953 - Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Kwan E, Jack E, Vesprini DJ, Kuperstein G, Abrahamson JL, Fan I, Wong B, Narod SA. Risch HA, et al. Am J Hum Genet. 2001 Mar;68(3):700-10. doi: 10.1086/318787. Epub 2001 Feb 15. Am J Hum Genet. 2001. PMID: 11179017 Free PMC article. - Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.
Casey MJ, Bewtra C, Hoehne LL, Tatpati AD, Lynch HT, Watson P. Casey MJ, et al. Gynecol Oncol. 2000 Sep;78(3 Pt 1):278-87. doi: 10.1006/gyno.2000.5861. Gynecol Oncol. 2000. PMID: 10985881 Review. - Breast cancer susceptibility genes. BRCA1 and BRCA2.
Brody LC, Biesecker BB. Brody LC, et al. Medicine (Baltimore). 1998 May;77(3):208-26. doi: 10.1097/00005792-199805000-00006. Medicine (Baltimore). 1998. PMID: 9653432 Review.
Cited by
- Clinical characteristics and prognostic implications of BRCA-associated tumors in males: a pan-tumor survey.
Sun P, Li Y, Chao X, Li J, Luo R, Li M, He J. Sun P, et al. BMC Cancer. 2020 Oct 14;20(1):994. doi: 10.1186/s12885-020-07481-1. BMC Cancer. 2020. PMID: 33054725 Free PMC article. - Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations.
Spain BH, Larson CJ, Shihabuddin LS, Gage FH, Verma IM. Spain BH, et al. Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13920-5. doi: 10.1073/pnas.96.24.13920. Proc Natl Acad Sci U S A. 1999. PMID: 10570174 Free PMC article. - Impacts of Subtype on Clinical Feature and Outcome of Male Breast Cancer: Multicenter Study in Korea (KCSG BR16-09).
Lee J, Lee KS, Sim SH, Chae H, Sohn J, Kim GM, Lee KH, Kang SH, Jung KH, Jeong JH, Byun JH, Koh SJ, Lee KE, Lim S, Kim HJ, Won HS, Park HS, Lee GJ, Hong S, Baek SK, Lee SI, Choi MY, Woo IS. Lee J, et al. Cancer Res Treat. 2023 Jan;55(1):123-135. doi: 10.4143/crt.2021.1561. Epub 2022 Mar 24. Cancer Res Treat. 2023. PMID: 35344650 Free PMC article. - Inherited BRCA2 mutations in African Americans with breast and/or ovarian cancer: a study of familial and early onset cases.
Kanaan Y, Kpenu E, Utley K, Adams-Campbell L, Dunston GM, Brody LC, Broome C. Kanaan Y, et al. Hum Genet. 2003 Oct;113(5):452-60. doi: 10.1007/s00439-003-0999-0. Epub 2003 Aug 26. Hum Genet. 2003. PMID: 12942367 - BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2.
Schubert EL, Lee MK, Mefford HC, Argonza RH, Morrow JE, Hull J, Dann JL, King MC. Schubert EL, et al. Am J Hum Genet. 1997 May;60(5):1031-40. Am J Hum Genet. 1997. PMID: 9150150 Free PMC article.
References
- Proc Natl Acad Sci U S A. 1988 May;85(9):3044-8 - PubMed
- Genet Epidemiol. 1996;13(2):193-205 - PubMed
- Am J Hum Genet. 1991 Feb;48(2):232-42 - PubMed
- J Natl Cancer Inst. 1991 Jun 19;83(12):849-54 - PubMed
- Cancer. 1993 Feb 15;71(4):1273-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous